NAA35: A Potential Drug Target and Biomarker (G60560)

Target Name: NAA35

NCBI ID: G60560

NAA35

NAA35: A Potential Drug Target and Biomarker

N-alpha-acetyltransferase 35 (NAA35) is a protein that is expressed in various tissues and cell types in the human body. NAA35 plays a critical role in the regulation of cell growth and differentiation, and is involved in the development and maintenance of tissues such as muscles, bones, and skin.

Recent studies have identified NAA35 as a potential drug target and biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. NAA35 has also been shown to be involved in a variety of cellular processes that are important for human health, including cell signaling, DNA replication, and stress response.

One of the key reasons for the potential utility of NAA35 as a drug target is its involvement in the regulation of cell growth and differentiation. NAA35 is known to play a role in the regulation of cell proliferation, and has been shown to be involved in the control of cell cycle progression. This involvement in cell growth and differentiation makes NAA35 a potential target for drugs that are designed to inhibit cell proliferation or promote cell differentiation.

Another potential use of NAA35 as a drug target is its role in the regulation of cellular stress response. NAA35 has been shown to be involved in the regulation of cellular stress response, and has been shown to play a role in the regulation of cellular stress responses that are important for human health. This involvement in cellular stress response makes NAA35 a potential target for drugs that are designed to promote cellular stress responses or inhibit cellular stress responses that are pathological.

In addition to its potential as a drug target, NAA35 has also been shown to be a potential biomarker for a variety of diseases. For example, NAA35 has been shown to be involved in the regulation of cellular processes that are important for the development and maintenance of tissues, such as muscles, bones, and skin. This involvement in tissue regulation makes NAA35 a potential biomarker for diseases that are characterized by the dysfunction of tissues, such as cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, NAA35 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of NAA35 in cellular processes and its potential as a drug and biomarker.

Protein Name: N-alpha-acetyltransferase 35, NatC Auxiliary Subunit

Functions: Auxillary component of the N-terminal acetyltransferase C (NatC) complex which catalyzes acetylation of N-terminal methionine residues. Involved in regulation of apoptosis and proliferation of smooth muscle cells

The "NAA35 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NAA35 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets